Fundraising Fox

Ensho Therapeutics

Morris Plains, US · Founded 2024 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

EW
Emily WengExecutive Officer
BK
Bittoo KanwarExecutive Officer
JA
James Andrew WhitneyExecutive Officer
NB
Neena Bitritto-GargExecutive Officer, Director, Promoter
MM
Matthew McKevittExecutive Officer

Investors · 1

Global BioAccess FundNew York · $10M

Reported raises · per SEC filings

Form D private placements
▶$20MofferedFeb 2026 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Carlos SolorzanoDirector
  • Danielle FryExecutive Officer
  • Gerhard HagnExecutive Officer
  • Eric PhamDirector
  • Arash RassoulpourDirector
Offering amount
$20M
Minimum investment
$1
First sale
Jan 2026
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$22.5MraisedSep 2025 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Neena Bitritto-GargExecutive Officer, Director, Promoter
  • Emily WengExecutive Officer
  • Eric PhamDirector
  • Matthew McKevittExecutive Officer
  • Arash RassoulpourDirector
  • Carlos SolorzanoDirector
  • James WhitneyExecutive Officer
  • Danielle FryExecutive Officer
  • Bittoo KanwarExecutive Officer
Offering amount
$22.5M
Amount sold
$22.5M
Proceeds to insiders
$1M
First sale
Jun 2025
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedNov 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Danielle FryExecutive Officer
  • Matthew McKevittExecutive Officer
  • Neena Bitritto-GargExecutive Officer, Director, Promoter
  • James Andrew WhitneyExecutive Officer
  • Emily WengExecutive Officer
  • Bittoo KanwarExecutive Officer
Offering amount
$12.5M
Amount sold
$5M
Proceeds to insiders
$500K
First sale
Oct 2024
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$400KraisedAug 2024 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Emily WengExecutive Officer
  • Bittoo KanwarExecutive Officer
  • James Andrew WhitneyExecutive Officer
  • Neena Bitritto-GargExecutive Officer, Director, Promoter
  • Matthew McKevittExecutive Officer
Offering amount
$2M
Amount sold
$400K
Proceeds to insiders
$500K
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.